Skip to content
Preprint · CC-BY via OpenAlex

Metformin-induced longevity is associated with retrotransposon dynamics in yeast chronological aging

Jimena Meneses-Plascencia, Ericka Moreno‐Méndez, Diana Ascencio, Cesia Pérez-Aguilar, Michelle Munguía-Figueroa, Cei Abreu‐Goodger, Soledad Funes, Alexander DeLuna

bioRxiv (Cold Spring Harbor Laboratory) · 2025

Abstract

Abstract The widely used antidiabetic drug metformin extends lifespan across diverse model organisms, from yeast to primates. However, the cellular mechanisms underlying its anti-aging effects remain only partially understood. Here, we combined large-scale genetic screening and high-resolution lifespan phenotyping with transcriptomic and proteomic analyses to provide a systems view of metformin’s impact on the chronological lifespan of Saccharomyces cerevisiae . Unexpectedly, we uncovered pronounced gene-drug interactions between metformin and chromatin-modifying factors. Specifically, deletions of Set3C histone deacetylation complex subunits phenocopied the longevity effect of metformin, with no additive benefit when combined, suggesting convergence on shared pathways. Transcriptome profiling further revealed that metformin reprogrammed stationary-phase gene expression, with Ty1-copia retrotransposons emerging as a consistently induced signature, thereby suggesting a possible mechanism for the observed interactions with Set3C regulation. Paradoxically, TYA Gag-like protein levels and retrotransposition frequency were modestly reduced, indicating an uncoupling between transcriptional activation and retromobility. Proteome analysis revealed increased abundance of mitochondrial and stress-response proteins as primary outcomes of metformin exposure, both known modulators of Ty1 dynamics in yeast. Together, our findings position chromatin regulation and retrotransposon expression as integral components of metformin’s pro-longevity mechanisms, expanding its influence beyond signaling, metabolism, and stress response. Highlights Large-scale genetic screening reveals that deletions of Set3C histone deacetylase phenocopy metformin-induced longevity. Metformin consistently induces Ty1 retrotransposon transcription but reduces Gag protein abundance and retromobility. Proteomic changes highlight mitochondrial and stress-response proteins as primary outcomes of metformin exposure. Retrotransposon dynamics emerge as a key component associated with metformin-induced longevity.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1101/2025.09.07.674784
Canonical
link ↗
Fetched
2026-10-08 MST

Cite this

APA
Meneses-Plascencia, J., Moreno‐Méndez, E., Ascencio, D., Pérez-Aguilar, C., Munguía-Figueroa, M., Abreu‐Goodger, C., Funes, S., &amp; DeLuna, A. (2025). Metformin-induced longevity is associated with retrotransposon dynamics in yeast chronological aging. <em>bioRxiv (Cold Spring Harbor Laboratory)</em>. https://doi.org/10.1101/2025.09.07.674784
Vancouver
Meneses-Plascencia J, Moreno‐Méndez E, Ascencio D, Pérez-Aguilar C, Munguía-Figueroa M, Abreu‐Goodger C, et al. Metformin-induced longevity is associated with retrotransposon dynamics in yeast chronological aging. bioRxiv (Cold Spring Harbor Laboratory). 2025. doi:10.1101/2025.09.07.674784.
BibTeX
@unpublished{jimena2025Metfor, title = {Metformin-induced longevity is associated with retrotransposon dynamics in yeast chronological aging}, author = {Jimena Meneses-Plascencia and Ericka Moreno‐Méndez and Diana Ascencio and Cesia Pérez-Aguilar and Michelle Munguía-Figueroa and Cei Abreu‐Goodger and Soledad Funes and Alexander DeLuna}, journal = {bioRxiv (Cold Spring Harbor Laboratory)}, year = {2025}, doi = {10.1101/2025.09.07.674784}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings